仕佳光子(688313.SH):和敬中道已減持1.97%的股份 持股降至4.996%
格隆匯3月4日丨仕佳光子(688313.SH)公佈,2022年3月4日,公司收到和敬中道出具的《關於持股5%以上股東減持計劃時間結束的吿知函》。此次減持計劃期限已屆滿,和敬中道在上述減持計劃期間共計減持了902.9717萬股,佔公司總股本的1.97%。其中,通過集中競價交易方式減持了125.1717萬股,佔公司總股本的0.27%;通過大宗交易方式減持了777.8萬股,佔公司總股本的1.70%;通過協議轉讓或其他方式減持了0股,佔公司總股本的0。此次減持完成後,和敬中道持有公司股份2292.0283萬股,佔公司總股本的4.996%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.